Kamyar Keramatian

1.7k total citations
34 papers, 728 citations indexed

About

Kamyar Keramatian is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Speech and Hearing. According to data from OpenAlex, Kamyar Keramatian has authored 34 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Psychiatry and Mental health, 7 papers in Cognitive Neuroscience and 6 papers in Speech and Hearing. Recurrent topics in Kamyar Keramatian's work include Bipolar Disorder and Treatment (24 papers), Electroconvulsive Therapy Studies (16 papers) and Schizophrenia research and treatment (10 papers). Kamyar Keramatian is often cited by papers focused on Bipolar Disorder and Treatment (24 papers), Electroconvulsive Therapy Studies (16 papers) and Schizophrenia research and treatment (10 papers). Kamyar Keramatian collaborates with scholars based in Canada, Brazil and United States. Kamyar Keramatian's co-authors include Kalina Christoff, Lakshmi N. Yatham, Rachelle M. Smith, Trisha Chakrabarty, Burkhard Mädler, Alan Gordon, Ivan J. Torres, Gayatri Saraf, Irene Liu and Matthew L. Dixon and has published in prestigious journals such as PLoS ONE, NeuroImage and Brain Research.

In The Last Decade

Kamyar Keramatian

31 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kamyar Keramatian Canada 14 366 302 118 68 62 34 728
Haris Aslam United States 14 273 0.7× 222 0.7× 151 1.3× 47 0.7× 31 0.5× 41 650
Anne-Marie Ergis France 13 445 1.2× 388 1.3× 217 1.8× 77 1.1× 110 1.8× 25 822
Silvia Rigucci Italy 11 202 0.6× 206 0.7× 69 0.6× 47 0.7× 98 1.6× 19 521
Christophe Delaloye Switzerland 17 261 0.7× 360 1.2× 137 1.2× 44 0.6× 42 0.7× 21 658
Robert M. Cohen United States 13 272 0.7× 397 1.3× 95 0.8× 34 0.5× 157 2.5× 15 754
Ricardo Riyoiti Uchida Brazil 14 242 0.7× 179 0.6× 148 1.3× 37 0.5× 38 0.6× 38 583
Adina S. Fischer United States 12 239 0.7× 152 0.5× 138 1.2× 36 0.5× 81 1.3× 20 550
Anna Mané Spain 18 222 0.6× 583 1.9× 120 1.0× 68 1.0× 106 1.7× 70 902
Zafar Sharif United States 17 540 1.5× 577 1.9× 175 1.5× 53 0.8× 53 0.9× 34 964
Richelle Stiffler United States 13 300 0.8× 230 0.8× 142 1.2× 26 0.4× 29 0.5× 43 584

Countries citing papers authored by Kamyar Keramatian

Since Specialization
Citations

This map shows the geographic impact of Kamyar Keramatian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamyar Keramatian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamyar Keramatian more than expected).

Fields of papers citing papers by Kamyar Keramatian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamyar Keramatian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamyar Keramatian. The network helps show where Kamyar Keramatian may publish in the future.

Co-authorship network of co-authors of Kamyar Keramatian

This figure shows the co-authorship network connecting the top 25 collaborators of Kamyar Keramatian. A scholar is included among the top collaborators of Kamyar Keramatian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamyar Keramatian. Kamyar Keramatian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Procyshyn, Ric M., et al.. (2025). Acute dystonia following the two-injection start of aripiprazole once-monthly. BMJ Case Reports. 18(2). e263842–e263842. 1 indexed citations
3.
Torres, Ivan J., Erin E. Michalak, Trisha Chakrabarty, et al.. (2024). Relationship between subjective cognitive functioning and fluid and crystallized cognitive abilities in bipolar disorder. Journal of the International Neuropsychological Society. 30(8). 719–727.
4.
Keramatian, Kamyar, et al.. (2023). The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence. FOCUS The Journal of Lifelong Learning in Psychiatry. 21(4). 344–353. 10 indexed citations
5.
Keramatian, Kamyar & Emma Morton. (2023). Barriers to timely identification of bipolar disorder in youth: a multidimensional perspective. PubMed. 2. 1186722–1186722. 5 indexed citations
6.
Keramatian, Kamyar, et al.. (2023). Caring for youth with co-occurring substance use and severe psychiatric disorders: diagnostic challenges and clinical implications.. PubMed. 32(3). 202–208.
8.
Keramatian, Kamyar, et al.. (2021). Longitudinal grey matter changes following first episode mania in bipolar I disorder: A systematic review. Journal of Affective Disorders. 291. 198–208. 9 indexed citations
9.
Keramatian, Kamyar, et al.. (2021). Cariprazine in the Treatment of Bipolar Disorder: Within and Beyond Clinical Trials. Frontiers in Psychiatry. 12. 769897–769897. 10 indexed citations
10.
Keramatian, Kamyar, Ivan J. Torres, & Lakshmi N. Yatham. (2021). Neurocognitive functioning in bipolar disorder: What we know and what we don’t. Dialogues in Clinical Neuroscience. 23(1). 29–38. 30 indexed citations
11.
Chakrabarty, Trisha, et al.. (2020). Cognitive subgroups in first episode bipolar I disorder: Relation to clinical and brain volumetric variables. Acta Psychiatrica Scandinavica. 143(2). 151–161. 19 indexed citations
12.
Keramatian, Kamyar, Wayne Su, Gayatri Saraf, Trisha Chakrabarty, & Lakshmi N. Yatham. (2020). Preservation of Gray Matter Volume in Early Stage of Bipolar Disorder: A Case for Early Intervention: Préservation du volume de matière grise au stade précoce du trouble bipolaire: un cas pour intervention précoce. The Canadian Journal of Psychiatry. 66(2). 139–146. 7 indexed citations
13.
Chakrabarty, Trisha, Kamyar Keramatian, & Lakshmi N. Yatham. (2020). Treatment of Mixed Features in Bipolar Disorder: an Updated View. Current Psychiatry Reports. 22(3). 15–15. 9 indexed citations
14.
Pinto, Jairo Vinícius, Gayatri Saraf, Daniel Vigo, et al.. (2019). Cariprazine in the treatment of Bipolar Disorder: A systematic review and meta‐analysis. Bipolar Disorders. 22(4). 360–371. 18 indexed citations
15.
Keramatian, Kamyar, Alexander McGirr, Donna J. Lang, et al.. (2016). Structural brain changes in first episode mania with and without psychosis: Data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). The World Journal of Biological Psychiatry. 19(sup2). S30–S40. 11 indexed citations
16.
Kozicky, Jan‐Marie, Alexander McGirr, David J. Bond, et al.. (2016). Neuroprogression and episode recurrence in bipolar I disorder: A study of gray matter volume changes in first‐episode mania and association with clinical outcome. Bipolar Disorders. 18(6). 511–519. 37 indexed citations
17.
Dixon, Matthew L., et al.. (2010). Improved modulation of rostrolateral prefrontal cortex using real-time fMRI training and meta-cognitive awareness. NeuroImage. 55(3). 1298–1305. 89 indexed citations
18.
Smith, Rachelle M., Kamyar Keramatian, & Kalina Christoff. (2007). Localizing the rostrolateral prefrontal cortex at the individual level. NeuroImage. 36(4). 1387–1396. 94 indexed citations
19.
Keramatian, Kamyar, et al.. (2006). Mind-wandering with and without awareness: An fMRI study of spontaneous thought processes. Max Planck Digital Library. 28(28). 804–809. 15 indexed citations
20.
Khalili, Hosseinali, et al.. (2005). Effect of methylphenidate on ICU and hospital length of stay in patients with severe and moderate traumatic brain injury. Clinical Neurology and Neurosurgery. 108(6). 539–542. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026